Background {#S5}
==========

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has had a profound impact on global public health. The ongoing COVID-19 pandemic has presented numerous clinical management challenges further compounded by overwhelmed health systems. The initial critical care experience in Hubei province, and more broadly in China, inadequately informed preparations for what has been seen in Europe and North America.([@R1]) Healthcare providers have therefore continued to incorporate and evaluate interventions in real-time. In the setting of critical COVID-19 illness, SARS-CoV-2 infection often results in severe pneumonia and hypoxemia with many patients developing acute respiratory distress syndrome (ARDS).([@R2]) Hypoxemic respiratory failure with ARDS has poor outcomes overall and COVID-19 associated ARDS is no exception.([@R3], [@R4])

Several interventions for ARDS have been evaluated over the last two decades. In particular, prone positioning is one of few therapeutic interventions for patients with severe ARDS that has demonstrated improved oxygenation and a survival benefit.([@R5]) Awake prone positioning outside of the intensive care unit (ICU) is safe and may decrease respiratory rate and improve oxygenation with early application potentially delaying need for intubation in patients with COVID-19.([@R6]--[@R8]) In the ICU setting, prone positioning of patients receiving non-invasive ventilation or high-flow nasal canula, with or without sedation, may also be beneficial.([@R8]) Physiologically, prone positioning may improve matching of ventilation and perfusion, but studies have not linked physiologic changes to clinical outcomes, especially in COVID-19.([@R9], [@R10])

The South Bronx is a socioeconomically disadvantaged borough in New York City (NYC) that had the highest per capita COVID-19 case count in the United States at 2941 per 100,000 residents with very high hospitalization and death rates.([@R11], [@R12]) The pressing challenge that COVID-19 brought to NYC necessitated external support through the United States Departments of Defense and Homeland Security, re-distribution and up-training of local hospital staff, support from clinical volunteers, and augmentation through healthcare worker staffing agencies. Given the high volume of critically-ill patients admitted to the hospital, a multidisciplinary team was assembled to provide prone positioning given the support for the practice in other populations with ARDS.

We sought to determine if patients on mechanical ventilation with moderate to severe ARDS who underwent standardized prone positioning had lower mortality and improved within-person physiologic changes. As we rapidly evaluate drugs and interventions for COVID-19, it is crucial to understand if serial prone positioning could be a complementary therapeutic intervention for the most critically ill.

Methods {#S6}
=======

Study design {#S7}
------------

A cohort design with participants from the peak of hospitalizations for COVID-19 in exposed (prone positioning) and non-exposed (non-prone-positioning) groups. During the COVID-19 pandemic, much of the hospital was converted into make-shift intensive care units and virtually all inpatients had confirmed COVID-19. During this time, a multidisciplinary prone team including personnel from the United States Air Force Medical and Nursing Corps, the United States Army, civilian contractors, and hospital occupational and physical therapy was assembled to offer positioning maneuvers which were otherwise rarely done due to crisis operations. Details of the prone positioning process, including peri-maneuver checklists, team size and roles, supplies and team schedule are included in [Fig. 1](#F1){ref-type="fig"}. In brief, patients were ideally put in the prone position in the afternoon allowing at least 16 hours in position before returning to supine position the following morning. The prone team included a physician, respiratory therapist, registered nurse, runner, and at least two members to safely support patient movements. The respiratory therapist served as the default airway expert except when a physician or advanced practice provider was trained in advanced airway management and, in that case, these providers served as airway expert.

Setting and participants {#S8}
------------------------

Participants were identified from a single level 1 trauma hospital in the South Bronx, New York City, and were included across all hospital services (medicine, surgery, intensive care). All sequential adult patients (\>17 years of age) were included if they were intubated, had not undergone prone positioning by others, met criteria for prone positioning, and had confirmed SARS-CoV-2 infection by real-time real-time reverse transcription-polymerase chain nasal swab (Bio-Reference Laboratories, Inc., Elmwood Park, NJ, USA) from March 25 through May 2, 2020. The prone team offered positional services for mechanically ventilated patients who met the following criteria (established *a priori*): arterial oxygen partial pressure to fractional inspired oxygen (PaO~2~:FiO~2~) \<150 mm Hg, positive end-expiratory pressure (PEEP) \>10 cm of water and FiO~2~ \> 0.6. The ultimate decision for initiating and discontinuing positional movements was made by the primary team overseeing and coordinating care for each patient. Prone positioning was not mandatory, but was routinely available, 24 hours a day, seven days a week. The study received institutional review board approval (IRB \# 20 -- 007).

Measures and outcomes {#S9}
---------------------

The primary exposure was positional maneuvers, defined as regular alternation between prone and supine positioning. The primary outcomes of interest were in-hospital mortality and, among exposed patients, differences in physiological parameters in prone vs supine position. In the mortality analysis, every patient had at least 30 days elapse following initiation of, or meeting criteria for, prone positioning. Follow-up of unexposed controls began when the participant first met prone positioning criteria during the two weeks after intubation. In the analysis of positioning effects on physiologic parameters among exposed patients, repeated measures of the oxygenation index (OI), oxygenation saturation index (OSI), PaO~2~:FiO~2~ and SpO~2~:FiO~2~ were compared during periods of prone and supine positioning. Episodes of positioning separated by more than 48 hours were considered separately. The last physiologic measurement collected in the intervals between each positional change were used in the analysis. After the final positioning change, the last measurement collected within 24 hours was used. Confounders for both analyses were identified based on literature review and directed acyclic graphs. In particular, age, sex, race, body mass index (BMI), acute physiology and chronic health evaluation (APACHE-II) score and vasopressor use were the primary confounders by indication. In the mortality analysis, the APACHE-II score was evaluated at the time of intubation.([@R13]) BMI and age were categorized for ease of interpretation and clinical utility. The study team obtained the study data through manual electronic medical record chart abstraction (Epic Systems, Verona, WI, USA).

Statistical analysis {#S10}
--------------------

Characteristics of the cohort were summarized using descriptive statistics as appropriate. Fine-Gray models were used to assess the association between prone positioning and death, accounting for hospital discharge as a competing risk.([@R14]) Participants remaining in the hospital at the end of follow-up were censored. The proportional sub-distribution hazards assumption was assessed visually through cumulative incidence curves. To minimize confounding by indication, we used standard regression adjustment as well as a doubly robust approach adding stabilized inverse probability treatment weights (IPTWs) to the fully adjusted model.([@R15]--[@R17]) A sensitivity analysis was done to identify changes in results by excluding controls that died within 48 hours of intubation. In addition, number needed to treat was calculated by the inverse of the averaged absolute risk differences at 30 days, for all participants at their actual and counterfactual values of prone positioning, and in combination with their observed covariate values.([@R18])

Linear mixed models (LMMs) were used to assess the association of prone vs supine positioning with physiologic parameter levels among the exposed. Outcomes were natural log transformed to meet normality assumptions. The LMMs included nested random effects for participant and positioning episode, and allowed for autocorrelation of the residuals. In addition to estimating overall positional effects, we also estimated these effects in days 1--3 and 4--7 of each episode. Pearson correlation coefficients were also used to characterize degree of agreement for OI, OSI, PaO2:FiO2 and SpO2:FiO2, to support clinical utility in practice. Analyses were performed in Stata (Version 16, StataCorp, College Station, TX, USA).

Results {#S11}
=======

During the study period, 335 individuals were intubated and placed on mechanical ventilation. Sixty-two underwent prone positioning while 199 who did not undergo positioning changes, but met criteria to do so, were selected as contemporary controls. Seventy-four individuals were excluded for failing to meeting prone positioning criteria or for having undergone prone positioning by providers outside of the standard protocol. A study flow diagram depicts the inclusion and exclusion of participants across groups in [Fig. 2](#F2){ref-type="fig"}. Overall, study participants were older, male and mostly self-reported Hispanic or Black. The majority of participants were obese. Diabetes and obstructive lung disease were the most common comorbidities. Most patients were critically ill and septic on admission with a median APACHE-II score at intubation of 17. Most participants required mechanical ventilation at hospital admission (i.e., intubated in the emergency room) and almost all patients (85%) received at least some amount of hydroxychloroquine as was consistent with hospital policy during the time. Most patients ultimately expired within two weeks. Compared to the control group, the participants who underwent prone positioning were younger (60 versus 66 years old) and were more frequently classified as severe rather than critical on admission to the hospital. Proportions of sepsis on admission and median APACHE-II scores at the time of intubation were similar across groups, but the prone positioning intervention group had less ARDS on admission. Full baseline, demographic and outcome data is summarized in [Table 1](#T1){ref-type="table"}.

Prone positioning and mortality {#S12}
-------------------------------

Compared to contemporary controls, the prone positioning group had fewer deaths and a longer time to death in those who expired, in spite of similar length of stay and ventilator-free days. Estimates of the association between prone positioning and mortality are summarized in [Table 2](#T2){ref-type="table"}. Unadjusted and adjusted competing risks analysis showed that exposed patients were at reduced risk of death (SHR 0.51, 95% CI 0.39--0.66, p\< 0.005 and SHR 0.57, 95% CI 0.42--0.76, p \< 0.005, respectively) compared to unexposed controls. In the doubly-robust analysis adding stabilized IPTWs, inferences were similar (SHR 0.61, 95% CI 0.46--0.80, p \< 0.005) and for every eight patients that underwent prone positioning, one in-hospital death was averted. We found no evidence for violation of the proportional hazards assumption through visual inspection of cumulative incidence curves ([Fig. 3](#F3){ref-type="fig"}). Covariate effect estimates are available in [Table 3](#T3){ref-type="table"}. A sensitivity analysis with removal of controls who died within 48 hours of intubation (N = 18) showed similar results.

Prone positioning and physiologic parameters {#S13}
--------------------------------------------

[Figure 4](#F4){ref-type="fig"} shows the mean trajectories of physiologic parameters over time. Improvements were seen for days 1--3 in the OSI, P~a~O~2~:FiO~2~, S~p~O~2~:FiO~2~ and P~a~O~2~. For days 4--7 of prone positioning, improvement was seen in the P~a~O~2~:FiO~2~, S~p~O~2~:FiO~2~ and P~a~O~2~. Only the OI failed to show improvement at any time and OSI did not show improvement for days 4--7. During crisis operations with enhanced infection control and use of transport ventilators for routine ventilation, it may be difficult to obtain P~a~O~2~ and mean airway pressure values and so proxy variables may be helpful. We therefore looked at Pearson correlation coefficients amongst ratios and indices. Overall, P~a~O~2~:FiO~2~ and S~p~O~2~:FiO~2~ are moderately correlated (*p* = −0.51), and OSI and OI, and OSI and S~p~O~2~:FiO~2~, are closely correlated (p = 0.84 and *p* = −0.80, respectively). The correlations did not differ when split into days 1--3 and 4--7. Results are summarized in [Fig. 5](#F5){ref-type="fig"}.

In analyses using LMMs to estimate the association of positioning with physiological indices, 19 of 62 exposed participants contributed more than one episode. In these analyses, prone vs supine positioning was significantly associated with overall improvement in P~a~O~2~:FiO~2~ ([Table 4](#T4){ref-type="table"}). In models allowing positioning effects to differ in days 1--3 and 4--7, prone positioning was associated with improved OSI during days 1--3 (p \< 0.01) as well as improved OSI, OI and P~a~O~2~:FiO~2~ during days 4--7 (p \< 0.05, p \< 0.01 and p\< 0.001, respectively). No clear evidence for interaction between positioning and time was found.

Discussion {#S14}
==========

We report results from a comprehensive cohort study assessing the potential benefits of prone positioning in COVID-19 patients with moderate to severe ARDS. We found a nearly 40% reduction in mortality with prone positioning, an effect that appears sustained on cumulative incidence curves. With respect to physiologic parameters, there were meaningful changes across all ratios and indices to suggest that prone positioning is associated with improvements in within-person physiology and that the benefit may persist beyond three days. Our findings across both analyses were robust to various adjustments, modifications, sensitivity analyses and nested comparative testing.

Fundamentally, this study has three key findings. First, we demonstrated a mortality benefit with prone positioning with a number needed to treat of eight. The durability of the finding is important, and ensuring that it can be replicated in other settings will be essential to justify a recommendation, but we have no evidence to attribute the survival benefit in the intervention arm to bias. Second, it appears that there is a benefit to additional days of prone positioning beyond 3 days. The effect seen with 4--7 days of prone positioning may be heavily influenced by a smaller group that realized a differential benefit, but 34 of 89 positioning sequences resulted in at least four days of intervention, representing a relatively large proportion of individuals. Third, prone positioning resulted in significant changes in physiologic parameters which may support the underlying hypothesis that prone positioning improves ventilation-perfusion matching.([@R9], [@R10]) Additionally, we demonstrated the utility of relatively accessible clinical information in the ICU as reasonable surrogates to monitor changes in physiology.

Our results are consistent with recent multi-center data suggesting a mortality benefit of prone positioning in patients with ARDS whether intubated or not.([@R6]--[@R8], [@R19], [@R20]) There are recommendations for prolonged prone positioning of 12--16 hours daily for mechanically ventilated adult patients with COVID-19 and refractory hypoxemic respiratory failure,([@R21]) but the optimal duration of the intervention, its' impact on physiologic parameters and details regarding how to organize and structure an intervention team during a crisis have not been completely evaluated. We acknowledge that prone positioning in mechanically ventilated patients is a resource-intensive intervention, particularly in overwhelmed healthcare systems during pandemic conditions. Before adopting prone positioning techniques, staff education and commitment is paramount. If justified by hospitalized patient volume, we recommend identifying personnel and assigning them to a dedicated prone team and tailoring readily available checklists to institutional needs and constraints ([Fig. 1](#F1){ref-type="fig"}).([@R22])

Some limitations of this study should be noted. First, this is a single center retrospective cohort study in a resource constrained environment under crisis operations. As a result, although patients had critical care needs, they were frequently cared for in ad-hoc intensive care units by non-critical care personnel. The decision to initiate or discontinue the intervention under study was left to the treating primary team without defining endpoints. We attempted to address any residual confounding through IPTW and no differences in the results were noted. If the prone team was consulted and the patient had moderate to severe ARDS and met criteria for prone positioning, it was felt that they could benefit from the intervention in addition to lung protective ventilation. Although this was pragmatic for this setting, if prone positioning is implemented elsewhere, the prone teams could consider establishing an opt-out approach with tailored entry and exit criteria, normal cadence of evaluation for candidacy for prone positioning and a mechanism for real-time data capture and quality control assessments. Finally, the results may not be readily generalizable to all populations, in particular those with milder disease and those that don't reflect the ethnic diversity seen in the Bronx. The institutional mortality proportion was high (\>75%) and therefore the impact of the intervention may be attenuated in the setting of advanced interventions (e.g., extracorporeal membrane oxygenation).

There are also some notable strengths of this work. We were able to collect detailed physiologic data in a structured manner to systematically evaluate the impact of the intervention. Also, our population has been gravely understudied in the COVID-19 pandemic and we've been able to contribute significantly to both describing their clinical course as well as critical care interventions for socioeconomically marginalized minority populations. Regarding outcome, we were able to include all patients who would have been eligible for prone positioning as controls creating a sound counterfactual for a contemporaneous comparison of both exposed and unexposed. Finally, compared to existing literature for patients with COVID-19, this study provides results for a large intervention group.

Conclusions {#S15}
===========

In summary, we present data supporting prone positioning as an intervention to prolong survival and improve physiologic parameters in patients on mechanical ventilation with moderate to severe ARDS due to COVID-19. The findings should be replicated across institutions, but prone positioning may be an important consideration for health systems, particularly in the setting of an evolving suite of complementary interventions in the care of such vulnerable patients.
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###### 

Baseline characteristics, including demographic and clinical presentation and outcomes, for all participants in the prone positioning intervention and non-prone positioning groups.

                                                                                                                                   Overall                       Underwent prone positioning   Did not undergo prone positioning
  -------------------------------------------------------------------------------------------------------------------------------- ----------------------------- ----------------------------- -----------------------------------
  Age, years (median, IQR)                                                                                                         64.0 (55.0--73.0)             60.0 (54.3--66.5)             66.0 (55.0--74.5)
  Age (years), No. (%)                                                                                                                                                                         
  \< 41 years                                                                                                                      13 (5.0%)                     3 (4.8%)                      10 (5.0%)
  41--60 years                                                                                                                     85 (32.6%)                    27 (43.5%)                    58 (29.1%)
  61--80 years                                                                                                                     131 (50.2%)                   31 (50.0%)                    100 (50.3%)
  \> 80 years                                                                                                                      32 (12.3%)                    1 (1.6%)                      31 (15.6%)
  Sex, female, No. (%)                                                                                                             99 (37.9%)                    20 (32.3%)                    79 (39.7%)
  Race, No. (%)                                                                                                                                                                                
  Hispanic                                                                                                                         170 (65.1%)                   38 (61.3%)                    132 (66.3%)
  Black                                                                                                                            63 (24.1%)                    12 (19.4%)                    51 (25.6%)
  Asian                                                                                                                            2 (0.8%)                      0                             2 (1.0%)
  White                                                                                                                            6 (2.3%)                      0                             6 (3.0%)
  Other                                                                                                                            20 (7.7%)                     12 (19.4%)                    8 (4.0%)
  Body mass index, kg/m^2^ (median, IQR)                                                                                           31.0 (27.1--6.8)              30.9 (28.3--35.9)             31.0 (26.7--37.2)
  Body mass index, No. (%)                                                                                                                                                                     
  \< 18.5 kg/m^2^                                                                                                                  3 (1.1%)                      0                             3 (1.5%)
  18.5--24.9 kg/m^2^                                                                                                               33 (12.6%)                    5 (8.1%)                      28 (14.1%)
  25--29.9 kg/m^2^                                                                                                                 78 (29.9%)                    19 (30.6%)                    59 (29.6%)
  ≥ 30 kg/m^2^                                                                                                                     147 (56.3%)                   38 (61.3%)                    109 (54.8%)
  **Clinical symptoms on presentation, No. (%)**                                                                                                                                               
                                                                                                                                                                                               
  Fever                                                                                                                            159 (60.9%)                   41 (66.1%)                    118 (59.3%)
  Cough                                                                                                                            190 (72.8%)                   54 (87.1%)                    136 (68.3%)
  Shortness of breath                                                                                                              220 (84.3%)                   54 (87.1%)                    166 (83.4%)
  GI symptoms (diarrhea or vomiting)                                                                                               36 (13.8%)                    12 (19.4%)                    24 (12.1%)
  Neurological symptoms (altered mental status or seizures)                                                                        55 (21.1%)                    5 (8.1%)                      50 (25.1%)
  **Comorbidities, No. (%)**                                                                                                                                                                   
  Current smoking                                                                                                                  14 (5.4%)                     1 (1.6%)                      13 (6.5%)
  Diabetes                                                                                                                         127 (48.7%)                   27 (43.5%)                    100 (50.3%)
  Obstructive lung disease (asthma or COPD)                                                                                        54 (20.7%)                    10 (16.1%)                    44 (22.1%)
  Congestive heart failure                                                                                                         19 (7.3%)                     1 (1.6%)                      18 (9.0%)
  Autoimmune disease (RA or SLE)                                                                                                   15 (5.7%)                     3 (4.8%)                      12 (6.0%)
  Chronic kidney disease (Stage ≥ 3)                                                                                               29 (11.1%)                    4 (6.5%)                      25 (12.6%)
  latrogenic immunosuppression                                                                                                     6 (2.3%)                      1 (1.6%)                      5 (2.5%)
  Cancer                                                                                                                           17 (6.5%)                     2 (3.2%)                      15 (7.5%)
  Human immunodeficiency virus infection                                                                                           5 (1.9%)                      2 (3.2%)                      3 (1.5%)
  Renal Transplantation                                                                                                            3 (1.1%)                      1 (1.6%)                      2 (1.0%)
  Charlson Comorbidity Index (median, IQR)                                                                                         3.0 (2.0--4.0)                3.0 (1.0--4.0)                3.0 (2.0--5.0)
  **Severity of COVID-19 on admission, No. (%)** ([@R13], [@R23])                                                                                                                              
  Moderate                                                                                                                         11 (4.2%)                     6 (9.7%)                      5 (2.5%)
  Severe                                                                                                                           86 (33.0%)                    27 (43.5%)                    59 (29.6%)
  Critical                                                                                                                         163 (62.5%)                   29 (46.8%)                    135 (67.8%)
  APACHE-II score (median, IQR) at intubation                                                                                      17.0 (12.0--27.0)             a17.5 (12.3--24.0)            17.0 (12.0--28.0)
  ARDS on admission                                                                                                                146 (55.9%)                   27 (43.5%)                    119 (59.8%)
  Sepsis on admission by Quick SOFA                                                                                                160 (61.3%)                   38 (61.3%)                    122 (61.3%)
  **Radiological characteristics, No. (%)**                                                                                                                                                    
  Bilateral reticulonodular opacities                                                                                              173 (66.3%)                   41 (66.1%)                    132 (66.3%)
  Ground-glass opacities                                                                                                           96 (36.8%)                    28 (45.2%)                    68 (34.2%)
  Focal consolidation                                                                                                              31 (11.9%)                    5 (8.1%)                      26 (13.1%)
  **Treatment and clinical course, No. (%)**                                                                                                                                                   
  BiPAP prior to mechanical ventilation                                                                                            37 (14.2%)                    17 (27.4%)                    20 (10.1%)
  Mechanical ventilation on admission                                                                                              186 (71.3%)                   31 (50.0%)                    155 (77.9%)
  Vasopressor use during hospital course                                                                                           221 (84.7%)                   53 (85.5%)                    168 (84.4%)
  Acute kidney injury during hospital course                                                                                       142 (54.4%)                   29 (46.8%)                    113 (56.8%)
  Hemodialysis required during hospital course                                                                                     35 (13.4%)                    16 (25.8%)                    19 (9.5%)
  Hydroxychloroquine administered                                                                                                  219 (83.9%)                   52 (83.9%)                    167 (83.9%)
  **Maneuvers and adjustments**                                                                                                                                                                
  Total maneuvers                                                                                                                  \-                            832                           \-
  Prone positioning                                                                                                                \-                            199                           \-
  Supine positioning                                                                                                               \-                            190                           \-
  Head, neck and shoulder adjustments                                                                                              \-                            443                           \-
  Maneuvers per participant (median, IQR)                                                                                          \-                            4 (2--8)                      \-
  **Outcomes (followed minimum of 30 days), no (%)**                                                                                                                                           
  Expired                                                                                                                          215 (82.4%)                   48 (77.4%)                    167 (83.9%)
  Discharged                                                                                                                       43 (16.4%)                    13 (21.0%)                    30 (15.1%)
  Ongoing hospitalization                                                                                                          3 (1.1%)                      1 (1.6%)                      2 (2.0%)
  Time to death (median, IQR) from admission                                                                                       8.2 (5.4--13.5)               15.3 (12.2--21.7)             7.2 (4.2--10.9)
  Length of stay, days (median, IQR)                                                                                               9.0 (5.4--14.3)               18.1 (13.1--26.9)             8.0 (5.0--14.0)
  Ventilator-free days (median, IQR)                                                                                               18.0 (13.0--22.0)             19.0 (16.0--20.0)             18.0 (12.0--22.0)
  Total extubations                                                                                                                29 (11.1%)                    7 (11.3%)                     22 (11.1%)
  Total re-intubations                                                                                                             8 (3.1%)                      1 (1.6%)                      7 (3.5%)
  Palliative extubations                                                                                                           10 (3.8%)                     2 (3.2%)                      8 (4.0%)
  Tracheostomy                                                                                                                     26 (10.0%)                    13 (21.0%)                    13 (6.5%)
  **Laboratory values on admission, \[reference range and units\] reported as median (IQR), N reported if different from total**                                                               
  White blood cell count \[4.8--10.8 × 10^3^ microliter\]                                                                          9.5 (6.9--12.9)               9.5 (7.1--12.6)               9.6 (6.8--13.1)
  Platelet count \[150 to 450 per microliter\]                                                                                     235 (182--301)                211.5 (186--283)              237.0 (181--303)
  Highest d-dimer during hospital course \[\< = 230 ng/milliliter\]                                                                3543 (1163--11838), n = 218   3988 (2049.5--13049.8)        3185 (1064--11739), n = 156
  C-reactive protein \[0--0.40 mg/deciliter\]                                                                                      28.0 (14.8--100.0), n = 244   24.1 (14.3--35.9), n = 61     30.8 (15.7--122.2), n = 183
  Highest creatinine during hospital course \[0.7--1.20 mg/deciliter\]                                                             3.7 (1.5--6.9), n = 260       3.8 (1.1--6.6)                3.7 (1.7--7.1), n = 198
  Lactate \[0.5--2.2 mmol/liter\]                                                                                                  2.1 (1.4--3.2), n = 223       2.0 (1.5--3.2), n = 56        2.1 (1.4--3.2), n = 167
  Procalcitonin \[\< = 0.08 ng/milliliter\]                                                                                        0.5 (0.2--1.3), n = 230       0.5 (0.3--1.3), n = 55        0.5 (0.2--1.3), n = 174
  lnterleukin-6 (0--5.5 pg/milliliter)                                                                                             19.8 (15.2--251.3), n = 220   16.1 (15.0--150.7), n = 57    32.3 (15.2--273.5), n = 162
  Ferritin \[20--250 ng/milliliter\]                                                                                               928.5 (515--1625), n = 225    871.0 (487--1466), n = 59     949 (531--1670), n = 166
  International normalized ratio \[0.8 to 1.1\]                                                                                    1.3 (1.1--1.4), n = 240       1.3 (1.2--1.4), n = 59        1.3 (1.1--1.4), n = 181

ARDS, acute respiratory distress syndrome; BiPAP bilevel positive airway pressure; COPD, chronic obstructive pulmonary disease; Pro-BNP-N-terminal pro b-type natriuretic peptide; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus

###### 

Association of a prone positioning intervention and time to death by Fine-Gray competing risks analysis.

  Model                           SHR    95% CI       *P*-value
  ------------------------------- ------ ------------ -----------
  Unadjusted                      0.51   0.39--0.66   \< 0.005
  Multivariate adjusted           0.57   0.42--0.76   \< 0.005
  Stabilized doubly robust IPTW   0.61   0.46--0.80   \< 0.005

Adjusted models control for age, sex, race, body-mass index, Apache II score and vasopressor use

###### 

Complete modeling output for Cox regression, with inverse-probability treatment weighting, adjustments, stabilized weights and accounting for competing risks.

  Variable                                     SHR                                95% CI                             *P*-value
  -------------------------------------------- ---------------------------------- ---------------------------------- ----------------------------------
  Prone positioning intervention (yes vs no)                                                                         
  No                                           Reference                          \-                                 \-
  Yes                                          0.61                               0.46--0.80                         \< 0.001
  Age                                                                                                                
  \< 41 years                                  Reference                          \-                                 \-
  41--60 years                                 2.68                               0.83--8.59                         0.10
  61--80 years                                 4.45                               1.39--14.20                        0.01
  \> 80 years                                  7.11                               2.13--23.76                        0.001
  Sex                                                                                                                
  Female                                       Reference                          \-                                 \-
  Male                                         1.06                               0.78--1.44                         0.69
  Race                                                                                                               
  White                                        Reference                          \-                                 \-
  Hispanic                                     0.33                               0.18--0.60                         \< 0.001
  Black                                        0.38                               0.20--0.73                         0.003
  Asian                                        [\*](#TFN3){ref-type="table-fn"}   [\*](#TFN3){ref-type="table-fn"}   [\*](#TFN3){ref-type="table-fn"}
  Other                                        0.34                               0.12--0.96                         0.04
  Body mass index, No. (%)                                                                                           
  \< 18.5kg/m^2^                               [\*](#TFN3){ref-type="table-fn"}   [\*](#TFN3){ref-type="table-fn"}   [\*](#TFN3){ref-type="table-fn"}
  18.5--24.9 kg/m^2^                           Reference                          \-                                 \-
  25--29.9 kg/m^2^                             0.85                               0.53--1.36                         0.49
  ≥ 30 kg/m^2^                                 0.87                               0.57--1.33                         0.52
  APACHE-II score                              1.01                               0.99--1.03                         0.26
  Vasopressor use                                                                                                    
  No                                           Reference                          \-                                 \-
  Yes                                          1.18                               0.76--1.85                         0.46

Observations were dropped from model due to small N and no variability in treatment (e.g. all within category were treated or all within category were not treated)

###### 

Adjusted associations of prone vs supine positioning with physiological parameters by linear mixed effects models.

                      Oxygenation index                                   Oxygenation saturation index                        PaO2:FiO2                                             SpO2:FiO2
  ------------------- --------------------------------------------------- --------------------------------------------------- ----------------------------------------------------- ---------------------
  Prone, overall      0.07 (−0.01, 0.2)                                   0.04 (−0.01, 0.08)                                  0.10 (0.04, 0.17)                                     −0.28 (−0.63, 0.08)
  \% *improvement*    *8%*                                                *4%*                                                *11%*                                                 *24%*
  Prone days 1--3     0.1 (−0.1, 0.1)                                     0.08 (0.0, 0.1)[\*\*](#TFN6){ref-type="table-fn"}   0.05 (−0.0, 0.1)                                      −0.32 (−0.7, 0.01)
  \% *improvement*    *1%*                                                *8%*                                                *5%*                                                  *27%*
  Prone days 4--7     0.30 (0.1, 0.5)[\*\*](#TFN6){ref-type="table-fn"}   −0.10 (−0.2, 0.0)                                   0.31 (0.2, 0.5)[\*\*\*](#TFN7){ref-type="table-fn"}   −0.03 (−1.0, 0.9)
  \% *improvement*    *38%*                                               *(9% worsening)*                                    *36%*[\*\*\*](#TFN7){ref-type="table-fn"}             *3%*
  Days 4--7 vs 1--3   −0.08 (−0.2, 0.1)                                   0.09 (−0.0, 0.2)                                    −0.8 (−0.2, 0.1)                                      0.06 (−0.7, 0.8)

Adjusted for age, sex, race, BMI, Apache II score, and vasopressor use

*P*\< 0.05,

*P*\< 0.01

*P*\< 0.001

[^1]: • Authors' contributions: M.C.S and S.M.B were responsible for concept and design of the study. PD.W., S.M.B, J.D.K. and E.V. analyzed and interpreted the data. M.C.S, I.A.S., D.L.J., W.A.S, M.C.S., S.A., V.P.G., AND V.P.M collected data. M.C.S. and S.M.B. performed the literature search and drafted the manuscript. K.K.C. and S.M.B. provided mentorship. All authors critically reviewed the draft, provided edits, saw and approved the final report.
